Abiopharma

🔍 Vizi Bradley (Director)

Company: RCM TECHNOLOGIES, INC. (RCMT)

Report Date: 2026-08-14

Detailed Transactions and Holdings:

• Sold 25,281 shares of Common Stock at $35.02 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,477,196.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 24,719 shares of Common Stock at $36.42 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,452,477.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 50,000 shares of Common Stock at $40.06 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,402,477.00 | transaction_form_type: 4 | Footnotes: F1, F4

Footnotes:

• F1: Represents a nondiscretionary sale by a plan established by the Reporting Person on December 7, 2023 in a manner intended to satisfy the requirements of Rule 10b5-1.
• F2: Represents the weighted average of a range of sale prices from $35.00 to $35.41. The reporting person undertakes to provide to the Staff of the Securities and Exchange Commission, the Company, or any stockholder of the Company, upon request, full information regarding the number of shares sold at each separate price.
• F3: Represents the weighted average of a range of sale prices from $36.03 to $37.10. The reporting person undertakes to provide to the Staff of the Securities and Exchange Commission, the Company, or any stockholder of the Company, upon request, full information regarding the number of shares sold at each separate price.
• F4: Represents the weighted average of a range of sale prices from $40.00 to $40.56. The reporting person undertakes to provide to the Staff of the Securities and Exchange Commission, the Company, or any stockholder of the Company, upon request, full information regarding the number of shares sold at each separate price.